A factual update for potential TAUG investors
Source: 2016-09-30 10Q Quarterly Report filed with OTC on 2016-12-05
All results are unaudited and all monetary figures are stated in US dollars.
Current Assets: $438 (including $0 cash)
Property & Equipment: $0
Current Liabilities: $2,961,254
Revenues: $0
Gross Profit: $0
Loss from operations: $311,265
Other income expense: $233,913
--------------
Weighted average number of shares outstanding: 1,361,122,811
TAUG plans to develop, market, distribute and potentially license a broad array of products and technologies that may help individuals who are affected by muscle tension.
It appears to me that TAUG is working on defining products, financing, marketing and distribution, but no products or services are currently offered.
----------------
TAUG, in its lawsuit, seeks damages against Cowan Gunteski (and its malpractice insurance policy) exceeding $4,000,000. There is no guarantee that the Company will be successful in this lawsuit.